Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▼DrugDate fromSubject
 28.10.2022Zentiva, k.s. (ZNT-1)00280Pyridoxin Léčiva (tbl 20x20 mg (blis.PVC/Al))28.10.2022O
 3.11.2025Zentiva, k.s. (ZNT-1)0029FRozetin 20 mg/10 mg (tbl flm 100x20 mg/10 mg (blis.OPA/Al/PVC/Al))30.10.2025U
 3.11.2025Zentiva, k.s. (ZNT-1)0030FRozetin 40 mg/10 mg (tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al))30.10.2025U
 13.1.2026Zentiva, k.s. (ZNT-1)0030FRozetin 40 mg/10 mg (tbl flm 30x40 mg/10 mg (blis.OPA/Al/PVC/Al))13.1.2026R
 15.12.2022Zentiva a.s. (ZNT-SK-2)00347Vitamin A-SLOVAKOFARMA kapsuly (cps 50x30 KU (liek.skl.hnedá))19.12.2022O
 29.10.2024Zentiva a.s. (ZNT-SK-2)00347Vitamin A-SLOVAKOFARMA kapsuly (cps 50x30 KU (liek.skl.hnedá))31.12.2024Z
 26.8.2025Baxter Slovakia s.r.o. (BAX-SK)0043FSodium Chloride 0,9% w/v Intravenous Infusion Bieffe (sol inf 20x500 ml (vak PE/PA/PP+ventil Twin))17.6.2025U
 21.11.2024BB Pharma a.s. (BBP-CZ-1)00448EREVIT 30 mg/ml (sol inj 5x1 ml (amp.skl.))1.12.2024Z
 21.11.2024BB Pharma a.s. (BBP-CZ-1)00449EREVIT 300 mg/ml (sol inj 5x1 ml (amp.skl.))1.12.2024Z
 30.7.2019BB Pharma a.s. (BBP-CZ-1)00464FOLIVIRIN (sus inj 5x2 ml (amp.skl.))29.7.2019O
 22.8.2023BB Pharma a.s. (BBP-CZ-1)00464FOLIVIRIN (sus inj 5x2 ml (amp.skl.))1.9.2023R
 27.8.2023BB Pharma a.s. (BBP-CZ-1)00498MAGNESIUM SULFURICUM BBP 100 mg/ml injekčný/infúzny roztok (sol inj 5x10 ml/1000 mg (amp.skl.))24.8.2023R
 24.8.2023BB Pharma a.s. (BBP-CZ-1)00499MAGNESIUM SULFURICUM BBP 200 mg/ml injekčný/infúzny roztok (sol inj 5x10 ml/2000 mg (amp.skl.))24.8.2023R
 1.10.2025Zentiva, k.s. (ZNT-1)00502Mesocain 1 % (sol inj 10x10 ml (amp. skl.))1.10.2025R
 24.10.2025Zentiva, k.s. (ZNT-1)00502Mesocain 1 % (sol inj 10x10 ml (amp. skl.))24.10.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)